CardioGenics Holdings Inc (CGNH)
USD 0.0
(99.0%)
USD 0.0
(99.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2015 | -1.91 Million USD | 28.49% |
| 2014 | -2.67 Million USD | 8.18% |
| 2013 | -2.91 Million USD | -123.13% |
| 2012 | -1.3 Million USD | 66.24% |
| 2011 | -3.87 Million USD | -91.4% |
| 2010 | -2.02 Million USD | 93.0% |
| 2009 | -28.92 Million USD | -921.47% |
| 2008 | -2.83 Million USD | 75.95% |
| 2007 | -11.77 Million USD | -223.77% |
| 2006 | -3.63 Million USD | -92.51% |
| 2005 | -1.88 Million USD | 5.81% |
| 2004 | -2 Million USD | 22.22% |
| 2003 | -2.57 Million USD | 35.87% |
| 2002 | -4.02 Million USD | 75.87% |
| 2001 | -16.66 Million USD | -0.01% |
| 2000 | -16.66 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2016 Q1 | -125.29 Thousand USD | 65.87% |
| 2015 Q4 | -367.12 Thousand USD | 39.96% |
| 2015 FY | -1.91 Million USD | 28.49% |
| 2015 Q1 | -1.06 Million USD | 22.35% |
| 2015 Q2 | 123.12 Thousand USD | 111.61% |
| 2015 Q3 | -611.49 Thousand USD | -596.65% |
| 2014 FY | -2.67 Million USD | 8.18% |
| 2014 Q3 | -565.62 Thousand USD | -66.48% |
| 2014 Q4 | -1.36 Million USD | -141.52% |
| 2014 Q1 | -408.39 Thousand USD | 81.11% |
| 2014 Q2 | -339.75 Thousand USD | 16.81% |
| 2013 Q4 | -2.16 Million USD | -585.28% |
| 2013 FY | -2.91 Million USD | -123.13% |
| 2013 Q3 | -315.42 Thousand USD | -50.3% |
| 2013 Q2 | -209.85 Thousand USD | 9.47% |
| 2013 Q1 | -231.8 Thousand USD | 36.31% |
| 2012 Q1 | -314.97 Thousand USD | 34.83% |
| 2012 Q4 | -363.94 Thousand USD | -53.28% |
| 2012 FY | -1.3 Million USD | 66.24% |
| 2012 Q3 | -237.43 Thousand USD | 39.38% |
| 2012 Q2 | -391.7 Thousand USD | -24.36% |
| 2011 FY | -3.87 Million USD | -91.4% |
| 2011 Q1 | -503.15 Thousand USD | 2.61% |
| 2011 Q2 | -715.68 Thousand USD | -42.24% |
| 2011 Q4 | -483.27 Thousand USD | 77.75% |
| 2011 Q3 | -2.17 Million USD | -203.54% |
| 2010 Q3 | -684.94 Thousand USD | -101.45% |
| 2010 FY | -2.02 Million USD | 93.0% |
| 2010 Q2 | -340 Thousand USD | 29.56% |
| 2010 Q1 | -482.69 Thousand USD | 96.64% |
| 2010 Q4 | -516.63 Thousand USD | 24.57% |
| 2009 Q1 | -423.8 Thousand USD | -37.27% |
| 2009 FY | -28.92 Million USD | -921.47% |
| 2009 Q4 | -14.35 Million USD | -0.37% |
| 2009 Q2 | -232.73 Thousand USD | 45.08% |
| 2009 Q3 | -14.3 Million USD | -6044.99% |
| 2008 Q3 | -231.05 Thousand USD | 59.38% |
| 2008 Q1 | -3.36 Million USD | -352.59% |
| 2008 FY | -2.83 Million USD | 75.95% |
| 2008 Q4 | -308.74 Thousand USD | -33.62% |
| 2008 Q2 | -568.87 Thousand USD | 83.09% |
| 2007 FY | -11.77 Million USD | -223.77% |
| 2007 Q4 | 1.33 Million USD | 118.8% |
| 2007 Q3 | -7.08 Million USD | -568.29% |
| 2007 Q2 | -1.05 Million USD | 67.66% |
| 2007 Q1 | -3.27 Million USD | -824.88% |
| 2006 Q4 | -354.35 Thousand USD | 76.81% |
| 2006 Q3 | -1.52 Million USD | -96.86% |
| 2006 Q2 | -776.25 Thousand USD | -5.26% |
| 2006 Q1 | -737.46 Thousand USD | -24.04% |
| 2006 FY | -3.63 Million USD | -92.51% |
| 2005 Q1 | -662.33 Thousand USD | -205.08% |
| 2005 FY | -1.88 Million USD | 5.81% |
| 2005 Q4 | -594.55 Thousand USD | -41.32% |
| 2005 Q3 | -420.71 Thousand USD | 28.55% |
| 2005 Q2 | -588.82 Thousand USD | 11.1% |
| 2004 Q2 | -718.18 Thousand USD | -163.28% |
| 2004 FY | -2 Million USD | 22.22% |
| 2004 Q4 | -217.1 Thousand USD | 56.56% |
| 2004 Q1 | -272.78 Thousand USD | 46.58% |
| 2004 Q3 | -499.72 Thousand USD | 30.42% |
| 2003 Q1 | -659.43 Thousand USD | -22.02% |
| 2003 Q4 | -510.66 Thousand USD | -12.17% |
| 2003 FY | -2.57 Million USD | 35.87% |
| 2003 Q3 | -455.25 Thousand USD | 50.71% |
| 2003 Q2 | -923.62 Thousand USD | -40.06% |
| 2002 Q3 | -796 Thousand USD | 20.3% |
| 2002 Q2 | -998.73 Thousand USD | 32.55% |
| 2002 Q1 | -1.48 Million USD | -98.66% |
| 2002 FY | -4.02 Million USD | 75.87% |
| 2002 Q4 | -540.41 Thousand USD | 32.11% |
| 2001 FY | -16.66 Million USD | -0.01% |
| 2001 Q3 | -1.29 Million USD | -3.22% |
| 2001 Q2 | -1.25 Million USD | 84.62% |
| 2001 Q1 | -8.17 Million USD | -37.66% |
| 2001 Q4 | -745.35 Thousand USD | 42.55% |
| 2000 Q1 | -3.07 Million USD | 0.0% |
| 2000 FY | -16.66 Million USD | 0.0% |
| 2000 Q4 | -5.93 Million USD | 15.6% |
| 2000 Q2 | -4.46 Million USD | -45.42% |
| 2000 Q3 | -7.03 Million USD | -57.57% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -35.91% |
| Arrayit Corporation | -3.31 Million USD | 42.203% |
| Atlantic International Corp. | -5.62 Million USD | 65.948% |
| Biocept, Inc. | -32.08 Million USD | 94.028% |
| Bioqual, Inc. | 483.48 Thousand USD | 496.36% |
| DermTech, Inc. | -100.88 Million USD | 98.101% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.095% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 91.126% |
| iMD Companies, Inc. | -200.63 Thousand USD | -855.125% |
| IDenta Corp. | 14.64 Thousand USD | 13186.069% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 338.943% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 5053.149% |
| InVitro International | 1553.00 USD | 123494.977% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 77.696% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -3197.639% |
| Medical Imaging Corp. | -3.02 Million USD | 36.609% |
| NovelStem International Corp. | -4.18 Million USD | 54.235% |
| Optigenex Inc. | -2.89 Million USD | 33.869% |
| PharmChem, Inc. | 845.1 Thousand USD | 326.757% |
| Proteome Sciences plc | -2.44 Million USD | 21.559% |
| Response Genetics, Inc | -20.18 Million USD | 90.506% |
| Rennova Health, Inc. | -3.29 Million USD | 41.807% |
| RushNet, Inc. | -607.02 Thousand USD | -215.69% |
| ScreenPro Security Inc. | -2.24 Million USD | 14.783% |
| Stella Diagnostics Inc. | -5.7 Million USD | 66.424% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 83.213% |
| Todos Medical Ltd. | -24.99 Million USD | 92.333% |